EMA on COVID-19: 'Fast-Tracking Does Not Mean Cutting Corners'
Agency Insists Safety And Efficacy Are Paramount
EMA advises caution on COVID-19 vaccine timelines, but says the outlook is more promising for new treatments.
You may also be interested in...
In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national and EU level.
Coronavirus Update: EU Regulator Skeptical On Vaccine This Year, Takeda Prepares Hyperimmune Alliance
EMA leader doesn't share Oxford's optimism, Takeda-led alliance forges ahead with plasma-derived therapy plans, Indian pharma firm Cadila gets into testing kits.
From speeding up PIP agreements to starting rolling reviews, the European Medicines Agency has explained how it is accelerating its regulatory procedures for COVID-19 treatments and vaccines.